Journal article
Peptide-based vaccination: where do we stand?
Abstract
PURPOSE OF REVIEW: Allergen-specific immunotherapy represents the only causative approach towards allergy treatment. Specific immunotherapy can, however, include allergic reactions and occasionally life-threatening anaphylaxis. Peptides have been evaluated as a potential therapeutic approach in atopic allergic disease because they have the potential to inhibit T-cell function but not induce anaphylaxis.
RECENT FINDINGS: Data from early clinical …
Authors
Francis JN; Larché M
Journal
Current Opinion in Allergy and Clinical Immunology, Vol. 5, No. 6, pp. 537–543
Publisher
Wolters Kluwer
Publication Date
December 2005
DOI
10.1097/01.all.0000191234.97760.88
ISSN
1528-4050